Literature DB >> 20376842

Collagen-induced arthritis.

Edward F Rosloniec1, Michael Cremer, Andrew H Kang, Linda K Myers, David D Brand.   

Abstract

The mouse model collagen-induced arthritis (CIA) is a widely studied autoimmune model of rheumatoid arthritis. In this model, autoimmune arthritis is induced by immunization with type II collagen (CII) emulsified in complete Freund's adjuvant. This unit describes the steps necessary for the acquisition, handling, and preparation of CII, in addition to the selection of mouse strains, proper immunization technique, and methods for evaluation of the incidence and severity of arthritis. In this model, the first signs of arthritis appear approximately 21 to 28 days after immunization. The protocols in this unit should provide the investigator with all the necessary information required to reproducibly induce a high incidence of CIA in genetically susceptible strains of mice, and to critically evaluate the pathology of the disease. (c) 2010 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376842     DOI: 10.1002/0471142735.im1505s89

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  44 in total

1.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.

Authors:  Karin N Westlund; Liping Zhang; Fei Ma; Helieh S Oz
Journal:  Transl Res       Date:  2011-11-08       Impact factor: 7.012

2.  Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway.

Authors:  Jeoung-Eun Park; David D Brand; Edward F Rosloniec; Ae-Kyung Yi; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  J Biol Chem       Date:  2020-01-13       Impact factor: 5.157

Review 3.  Modulation of autoimmune arthritis by environmental 'hygiene' and commensal microbiota.

Authors:  David Langan; Eugene Y Kim; Kamal D Moudgil
Journal:  Cell Immunol       Date:  2018-12-10       Impact factor: 4.868

4.  The role of Syk in peripheral T cells.

Authors:  Jeoung-Eun Park; Sirshendu Majumdar; David D Brand; Edward F Rosloniec; Ae-Kyung Yi; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  Clin Immunol       Date:  2018-04-16       Impact factor: 3.969

5.  CD8α⁺ dendritic cells improve collagen-induced arthritis in CC chemokine receptor (CCR)-2 deficient mice.

Authors:  Jessica M Ibarra; Marlon P Quinones; Carlos A Estrada; Fabio Jimenez; Hernan G Martinez; Seema S Ahuja
Journal:  Immunobiology       Date:  2011-04-07       Impact factor: 3.144

6.  Characterization of the Syk-Dependent T Cell Signaling Response to an Altered Peptide.

Authors:  Jeoung-Eun Park; Jeffrey A Rotondo; David L Cullins; David D Brand; Ae-Kyung Yi; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  J Immunol       Date:  2016-11-11       Impact factor: 5.422

7.  Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.

Authors:  Linda K Myers; David L Cullins; Jeoung-Eun Park; Ae-Kyung Yi; David D Brand; Edward F Rosloniec; John M Stuart; Andrew H Kang
Journal:  Clin Immunol       Date:  2015-05-14       Impact factor: 3.969

8.  T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.

Authors:  Linda K Myers; David L Cullins; David D Brand; Sandra Kleinau; John M Stuart; Andrew H Kang
Journal:  Arthritis Rheum       Date:  2011-09

9.  Molecular basis for T cell response induced by altered peptide ligand of type II collagen.

Authors:  Jeoung-Eun Park; David Cullins; Lillian Zalduondo; Stacey L Barnett; Ae-Kyung Yi; Sandra Kleinau; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

10.  The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Authors:  Seunghyun Kim; Ellis R Easterling; Lauren C Price; Savannah L Smith; John E Coligan; Jeoung-Eun Park; David D Brand; Edward F Rosloniec; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.